H71.10
Cholesteatoma of tympanum, unspecified ear
Clinical Classification Guidelines
Medical Intelligence & Overview
Cholesteatoma of the tympanum is a non-cancerous growth that develops in the middle ear, specifically within the tympanic cavity. Although benign, this growth can cause significant issues if left untreated, including damage to the surrounding structures and potential hearing loss. The condition is described under the ICD-10 code H71.10, emphasizing its occurrence in an unspecified ear.
Causes & Symptoms
Clinical Causes: Chronic ear infections (otitis media) that do not heal properly Eustachian tube dysfunction, leading to negative pressure in the middle ear Congenital factors, where abnormal skin formations are present from birth Trauma or injury to the ear, which can facilitate abnormal skin growth Previous ear surgeries or procedures that may disturb normal ear anatomy
Key Symptoms: Persistent hearing loss, often gradual Ear fullness or discomfort Recurrent or persistent ear infections Drainage or foul-smelling discharge from the ear Tinnitus (ringing or buzzing sounds in the ear) Dizziness or balance issues in advanced cases In some instances, visible or noticeable swelling behind the eardrum
Diagnostic & Treatment
Diagnosis Path: Diagnosis of cholesteatoma involves a combination of clinical examination and diagnostic testing. An otoscopic exam allows an ear specialist to visualize growths or abnormal tissue behind the eardrum. Audiography (hearing test) helps to assess the extent of hearing loss. Additional imaging, such as CT scans, may be ordered to evaluate the size of the cholesteatoma and any damage to the middle ear or surrounding bones. Accurate diagnosis is crucial to prevent complications and plan appropriate treatment.
Treatment Protocols: Treatment generally involves surgical removal of the cholesteatoma to prevent further damage and restore hearing. The surgical approach depends on the size and extent of the growth, and may include procedures such as removal of the growth, repairing damaged eardrum, and reconstructing middle ear structures if necessary. Postoperative care involves monitoring for recurrence and managing any residual hearing issues. In some cases, antibiotics or other medications may be prescribed to treat or prevent infections, but medication alone is not sufficient for cholesteatoma removal.
Clinical Advice & FAQs
Billing Guidance
Is H71.10 a billable ICD-10 code?
Yes, H71.10 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H71.10?
Clinical documentation must specify the nature of Cholesteatoma of tympanum, unspecified ear and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
